International researchers, including the National Food Institute of Denmark, have warned that the Congo Mpox epidemic is worsening, with the Mpox virus undergoing mutations that make the new variant, Class 1B, more infectious. This development raises concerns about the rapid spread of the disease, similar to the early days of the COVID-19 pandemic.

Genetic analyses of the 1B class, first identified in September 2023 in the Democratic Republic of Congo (DRC), reveal that this variant has undergone mutations that enhance its ability to spread between people. Scientists have identified three new subvariants, with one having spread beyond the initial outbreak in DRC to neighboring countries and even as far as Sweden and Thailand.

There are also alarming indications that Class 1B may involve a high risk of miscarriage. This new data was published in the scientific journal Nature Medicine and was authored by 16 researchers from six countries: DRC, Rwanda, Denmark, the United Kingdom, Spain, and the Netherlands.

Understanding the New Variant

The emergence of the Class 1B variant has changed the dynamics of the Mpox outbreak. Initially considered a zoonotic disease that primarily spread from animals to humans, Mpox became a significant public health concern in 2022, with outbreaks among men who have sex with men (MSM). However, the new 1B variant affects both men and women, with an increasing number of infections reported among healthcare workers and children.

Professor Frank Møller Aarestrup from the National Food Institute DTU, leading the Great-Life project, commented, “It is somewhat like Sars-Cov-2—the virus suffers mutations as it spreads. In the case of Class 1B, we notice that a certain subvariant seems to have become more effective in transmitting between people and has now been detected in several countries outside East Africa.”

“It is somewhat like Sar-Cov-2—the virus suffers mutations as it spreads. In the case of Class 1B, we notice that a certain subvariant seems to have become more effective in transmitting between people and has now been detected in several countries outside East Africa. In addition, the number of infected pregnant women who abort is raised among those we have tested, ”- Professor Frank Møller Aarestrup from the National Food Institute DTU

The Great-Life project, coordinated by the National Food Institute, aims to strengthen the ability to detect diseases in East Africa. The project focuses on implementing local PCR tests for viral diseases using portable equipment. This initiative was launched during the outbreak of the 1B variant in DRC, providing critical tools and expertise to local researchers and medical staff.

Global Collaboration and Prevention

The research underscores the urgent need for cross-border collaboration to contain the spread of Mpox. Currently, uncontrolled transmission of Class 1B is observed in eastern DRC and Burundi, with limited spread to other parts of East Africa. While international spreads are limited, Prof. Aarestrup emphasizes that immediate attention is crucial: “Although there is a certain international spread, we do not expect a large outbreak outside the epicenter in East Africa. However, this situation requires immediate attention. It is essential to avoid close contacts, especially sexual contacts, in high-risk areas.”

Potential Impact and Future Directions

With over 9,500 people positively tested for Mpox in the DRC by January 5, 2025, and an estimated mortality rate of 3.4%, the rapid growth of cases in the southern provinces of the DRC is deeply concerning. The virus’s increased transmissibility and the high risk of complications, such as miscarriage in pregnant women, call for enhanced global vigilance and local measures.

Local measures should include increased vaccination efforts and public sensitization campaigns on transmission paths. Global measures could involve travel recommendations against visiting high-risk areas and strict public health protocols to prevent the spread.

Case Studies and Practical Applications

The Great-Life project has been instrumental in rapidly detecting and responding to the 1B variant. For instance, the project identified the new variant in Kamituga, South Kivu Province, DRC, and developed a PCR test to specifically detect the 1B variant. This kind of precision testing is crucial for combating the outbreak.

In the United States, similar collaborations and advancements in viral detection could play a significant role in managing future health crises. The COVID-19 pandemic highlighted the importance of rapid testing and cross-agency collaboration. For instance, the rollout of the rapid antigen test expedited case detection, and similar models could be applicable to ongoing viral threats like Mpox.

Conclusion and Call to Action

The global health community must remain vigilant and proactive in addressing the evolving threat of the Mpox epidemic. As the Class 1B variant spreads, international cooperation, rigorous testing, and strategic vaccine development will be pivotal. The lessons learned from the Great-Life project and similar initiatives underscore the importance of timely public health interventions and robust surveillance systems.